Ramsay Hunt Syndrome
Also known as: Herpes zoster oticus
Herpes zoster oticus with peripheral facial nerve palsy, caused by reactivation of varicella zoster virus latent in the geniculate ganglion. It accounts for around 12 percent of facial palsies and carries a substantially worse prognosis than Bell palsy.
Pathophysiology
Reactivated virus produces ganglionitis, neuritis and inflammatory oedema within the fallopian canal, which is a rigid bony channel with the narrowest segment at the labyrinthine portion and the meatal foramen, roughly 0.68 mm in diameter. Swelling here produces compression, ischaemia and Wallerian degeneration. Because the virus produces direct neuronal destruction rather than the predominantly oedematous injury of Bell palsy, axonal loss is greater and recovery poorer.
Spread to adjacent cranial nerves is common. The vestibulocochlear nerve is involved in up to 40 percent through the internal auditory canal, and cranial nerves V, IX, X and XI may be affected, producing polycranial neuropathy.
Prognosis
- Complete recovery of facial function occurs in around 75 percent of Bell palsy but only 20 to 50 percent of Ramsay Hunt syndrome.
- Treatment within 72 hours substantially improves outcome, with recovery rates of around 75 percent when treated within 3 days falling to around 30 percent when treated after 7 days.
- Complete palsy at presentation, age over 50 years, diabetes, hypertension and associated vertigo or hearing loss all predict poorer recovery.
Risk factors: age over 60, immunosuppression, HIV, malignancy, diabetes, and physiological or psychological stress. Ramsay Hunt syndrome in a young adult should prompt HIV testing.

